A medical team at the University of Edinburgh has reached a milestone in preserving male fertility, carrying out a testicular tissue transplant on a 19-year-old man. The operation, performed in August and announced by the university on Thursday, is described as the first of its kind in the United Kingdom and only the second recorded worldwide.
The patient, who has chosen to remain anonymous, was sixteen in 2023 when a serious blood disorder forced him into intensive chemotherapy followed by a bone marrow transplant. Before starting that demanding treatment, doctors removed and froze a small sample of testicular tissue, aware that certain chemotherapy drugs destroy the cells responsible for producing sperm. Three years later, tests confirmed the team’s fears: no sperm at all in his semen, raising serious doubts about his ability to have children one day, even though he had come through the most dangerous stage of his illness.
Researchers then decided to reimplant part of the frozen tissue, betting on the ability of its stem cells to restart normal sperm production. The technique relies on specialised cells found only in testicular tissue, the sole cells capable of triggering and sustaining sperm production after puberty. It matters most for children facing cancer treatment, who cannot freeze sperm directly the way adult men and teenagers can, simply because their bodies do not yet produce any.
Professor Rod Mitchell, an endocrinology specialist at the University of Edinburgh who leads the project, explained that the effort to preserve testicular tissue in children at risk of infertility began more than a decade ago. It has now entered a decisive phase: testing whether that preserved tissue can genuinely be put back to use.
The patient is reported to be recovering well, though final results are not yet in. A biopsy of the transplanted tissue is planned in roughly eight months to check whether it is producing mature sperm. The University of Edinburgh says it has already preserved testicular tissue for more than 1,200 patients in the UK and around 3,100 worldwide, a figure that reflects just how much hope this still-experimental technique has raised for thousands of families confronting childhood cancer.
